2018 B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症的管理建议

2018-12-26 国外风湿免疫科相关专家小组 Rheumatology (Oxford). 2018 Dec 26.

B细胞靶向治疗与低丙种球蛋白血症的感染的关系越来越被人们认可。本文的主要目的是针对免疫球蛋白替代疗法治疗B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症提出共识建议。

中文标题:

2018 B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症的管理建议

英文标题:

Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases.

发布日期:

2018-12-26

简要介绍:

B细胞靶向治疗与低丙种球蛋白血症的感染的关系越来越被人们认可。本文的主要目的是针对免疫球蛋白替代疗法治疗B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症提出共识建议。 

拓展指南:自身免疫相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症的管理建议)] GetToolGuiderByIdResponse(projectId=1, id=d3bc81c001685644, title=2018 B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症的管理建议, enTitle=Recommendations for the management of secondary hypogammaglobulinaemia due to B cell targeted therapies in autoimmune rheumatic diseases., guiderFrom=Rheumatology (Oxford). 2018 Dec 26., authorId=null, author=, summary=B细胞靶向治疗与低丙种球蛋白血症的感染的关系越来越被人们认可。本文的主要目的是针对免疫球蛋白替代疗法治疗B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症提出共识建议。 , cover=, journalId=null, articlesId=null, associationId=893, associationName=国外风湿免疫科相关专家小组, associationIntro=null, copyright=0, guiderPublishedTime=Wed Dec 26 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<div>B细胞靶向治疗与低丙种球蛋白血症的感染的关系越来越被人们认可。本文的主要目的是针对免疫球蛋白替代疗法治疗B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症提出共识建议。 </div> <div><br> </div> 拓展指南:<strong>与<font color=red>自身免疫</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=5c0b21c001629585" title="2018 儿童时期自身免疫性胰腺炎的诊断和管理建议" target=_blank>2018 儿童时期自身免疫性胰腺炎的诊断和管理建议</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=064b11c00156e7f0" title="2018 实践建议:接受阿仑单抗治疗的多发性硬化患者自身免疫性疾病的监测和管理" target=_blank>2018 实践建议:接受阿仑单抗治疗的多发性硬化患者自身免疫性疾病的监测和管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=658ac1c0015a2807" title="《2017年欧洲儿科胃肠病、肝病和营养学会立场声明:儿童自身免疫性肝病的诊断和管理》摘译" target=_blank>《2017年欧洲儿科胃肠病、肝病和营养学会立场声明:儿童自身免疫性肝病的诊断和管理》摘译</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=79b6b1c001a838e8" title="中国自身免疫性脑炎诊治专家共识" target=_blank>中国自身免疫性脑炎诊治专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=d31f71c001ae01d0" title="自身免疫性溶血性贫血诊断与治疗中国专家共识(2017年版)" target=_blank>自身免疫性溶血性贫血诊断与治疗中国专家共识(2017年版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%87%AA%E8%BA%AB%E5%85%8D%E7%96%AB" target=_blank>有关自身免疫更多指南</a></ul>, tagList=[TagDto(tagId=85272, tagName=B细胞靶向治疗), TagDto(tagId=13489, tagName=自身免疫性疾病), TagDto(tagId=85273, tagName=继发性低丙种球蛋白血症)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8028, appHits=95, showAppHits=0, pcHits=6798, showPcHits=1782, likes=353, shares=3, comments=2, approvalStatus=1, publishedTime=Tue Jan 08 20:13:16 CST 2019, publishedTimeString=2018-12-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Tue Jan 08 20:13:16 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 08:08:19 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症的管理建议)])
2018 B细胞靶向治疗自身免疫性疾病继发性低丙种球蛋白血症的管理建议
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1051886, encodeId=4dd81051886aa, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:37:07 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011630, encodeId=00f0101163029, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:20:51 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-09-16 湘雅科教

    受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1051886, encodeId=4dd81051886aa, content=受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Thu Sep 16 11:37:07 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011630, encodeId=00f0101163029, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=未来将来, createdTime=Thu Aug 26 09:20:51 CST 2021, time=2021-08-26, status=1, ipAttribution=)]
    2021-08-26 未来将来

    学习了

    0